Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Acromegaly is not associated with irritable bowel syndrome: a pilot study.

Caglar E, Hatipoglu E, Niyazoglu M, Celik O, Tuncer M, Kadioglu P.

Neuro Endocrinol Lett. 2013;34(1):71-4.

PMID:
23524627
2.

Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.

Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P.

Gastroenterology. 2013 Dec;145(6):1262-70.e1. doi: 10.1053/j.gastro.2013.08.048. Epub 2013 Aug 28.

PMID:
23994201
3.

Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome.

Piche T, Ducrotté P, Sabate JM, Coffin B, Zerbib F, Dapoigny M, Hua M, Marine-Barjoan E, Dainese R, Hébuterne X.

Neurogastroenterol Motil. 2010 Jun;22(6):626-e174. doi: 10.1111/j.1365-2982.2010.01502.x. Epub 2010 Apr 19.

PMID:
20403099
4.

Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study.

Webb SM, Badia X, Surinach NL; Spanish AcroQol Study Group.

Eur J Endocrinol. 2006 Aug;155(2):269-77.

5.

Irritable bowel syndrome-type symptoms in female patients with mild systemic lupus erythematosus: frequency, related factors and quality of life.

García Carrasco M, Mendoza Pinto C, López Colombo A, Méndez Martínez S, Andari Sawaya R, Muñoz Guarneros M, Vázquez De Lara L, Lescas Hernández M, Montiel Jarquín A, Ramos Álvarez G, Schmulson M.

Neurogastroenterol Motil. 2013 Dec;25(12):958-66. doi: 10.1111/nmo.12230. Epub 2013 Sep 25.

PMID:
24112121
6.

Quality of life in female patients with acromegaly.

Celik O, Kadioglu P.

J Endocrinol Invest. 2013 Jun;36(6):412-6. doi: 10.3275/8761. Epub 2012 Nov 26.

PMID:
23211278
7.

Prevalence of irritable bowel syndrome in caregivers of patients with chronic diseases.

Remes-Troche JM, Torres-Aguilera M, Montes-Martínez V, Jiménez-García VA, Roesch-Dietlen F.

Neurogastroenterol Motil. 2015 Jun;27(6):824-31. doi: 10.1111/nmo.12556. Epub 2015 Mar 29.

PMID:
25817438
8.

Irritable bowel syndrome in haemodialysis: Prevalence, link with quality of life and depression.

Afsar B, Elsurer R, Yilmaz MI, Eyileten T, Yenicesu M.

Nephrology (Carlton). 2010 Mar;15(2):197-202. doi: 10.1111/j.1440-1797.2009.01189.x.

PMID:
20470279
9.

The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome.

Ozdil K, Sahin A, Calhan T, Kahraman R, Nigdelioglu A, Akyuz U, Sokmen HM.

BMC Gastroenterol. 2011 Aug 31;11:96. doi: 10.1186/1471-230X-11-96.

10.

The impact of irritable bowel syndrome on health-related quality of life: a Singapore perspective.

Wang YT, Lim HY, Tai D, Krishnamoorthy TL, Tan T, Barbier S, Thumboo J.

BMC Gastroenterol. 2012 Aug 9;12:104. doi: 10.1186/1471-230X-12-104.

11.

Irritable bowel syndrome in renal transplant patients: prevalence, link with quality of life, anxiety, and depression.

Gungor O, Kircelli F, Turan MN, Cetin O, Elbi H, Tatar E, Sertoz OO, Toz H.

Ren Fail. 2012;34(7):876-9. doi: 10.3109/0886022X.2012.690805. Epub 2012 Jun 8.

PMID:
22680982
12.

Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.

Engsbro AL, Begtrup LM, Kjeldsen J, Larsen PV, de Muckadell OS, Jarbøl DE, Bytzer P.

Am J Gastroenterol. 2013 Jun;108(6):972-80. doi: 10.1038/ajg.2013.15. Epub 2013 Feb 19.

PMID:
23419383
13.

Acromegaly is associated with higher frequency of female sexual dysfunction: experience of a single center.

Celik O, Hatipoglu E, Akhan SE, Uludag S, Kadioglu P.

Endocr J. 2013;60(6):753-61. Epub 2013 Feb 8.

14.

Endocrine cells in the ileum of patients with irritable bowel syndrome.

El-Salhy M, Gilja OH, Gundersen D, Hatlebakk JG, Hausken T.

World J Gastroenterol. 2014 Mar 7;20(9):2383-91. doi: 10.3748/wjg.v20.i9.2383.

15.

Partially hydrolyzed guar gum in pediatric functional abdominal pain.

Romano C, Comito D, Famiani A, Calamarà S, Loddo I.

World J Gastroenterol. 2013 Jan 14;19(2):235-40. doi: 10.3748/wjg.v19.i2.235.

16.

Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.

Mikocka-Walus A, Turnbull D, Moulding N, Wilson I, Andrews JM, Holtmann G.

J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1137-43. Epub 2007 Dec 7.

PMID:
18070012
17.

Irritable bowel syndrome in France: a common, debilitating and costly disorder.

Dapoigny M, Bellanger J, Bonaz B, Bruley des Varannes S, Bueno L, Coffin B, Ducrotté P, Flourié B, Lémann M, Lepicard A, Reigneau O.

Eur J Gastroenterol Hepatol. 2004 Oct;16(10):995-1001.

PMID:
15371923
18.

Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly.

T'Sjoen G, Bex M, Maiter D, Velkeniers B, Abs R.

Eur J Endocrinol. 2007 Oct;157(4):411-7.

19.

Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.

Wong RK, Palsson OS, Turner MJ, Levy RL, Feld AD, von Korff M, Whitehead WE.

Am J Gastroenterol. 2010 Oct;105(10):2228-34. doi: 10.1038/ajg.2010.200. Epub 2010 May 25.

20.

A survey about irritable bowel syndrome in South Korea: prevalence and observable organic abnormalities in IBS patients.

Park KS, Ahn SH, Hwang JS, Cho KB, Chung WJ, Jang BK, Kang YN, Kwon JH, Kim YH.

Dig Dis Sci. 2008 Mar;53(3):704-11. Epub 2007 Aug 24.

PMID:
17717743

Supplemental Content

Support Center